Current Medical Research and Opinion

The dose of aspirin for the prevention of cardiovascular and cerebrovascular events
pp. 1239-1248(10)
Authors: Fisher, Matt; Knappertz, Volker

The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases
pp. 1249-1256(8)
Authors: Brankin, Eamonn; Walker, Mel; Lynch, Niall; Aspray, Terence; Lis, Yvonne; Cowell, Warren

Secondary insomnia in the primary care setting: review of diagnosis, treatment, and management
pp. 1257-1268(12)
Author: Culpepper, Larry

Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief
pp. 1269-1276(8)
Authors: Schley, Marcus; Legler, Andreas; Skopp, Gisela; Schmelz, Martin; Konrad, Christoph; Rukwied, Roman

Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial
pp. 1277-1285(9)
Authors: Potvin, Stéphane; Stip, Emmanuel; Lipp, Olivier; Élie, Robert; Mancini-Marië, Adham; Demers, Marie-France; Roy, Marc-André; Bouchard, Roch-Hugo; Gendron, Alain

Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome
pp. 1287-1294(8)
Authors: Widimský, Jiří; Sirotiaková, Jana

Disease control in asthmatic children seen in private practice in Switzerland
pp. 1295-1306(12)
Authors: Moeller, Alexander; Steurer-Stey, Claudia; Suter, Herbert; Hofer, Michael; Peter, Manuela; Brooks-Wildhaber, Joanne; Hammer, Jürg; Wildhaber, Johannes H.

Single-day famciclovir therapy for recurrent genital herpes
pp. 1307-1310(4)
Authors: Whitley, Richard; Diaz-Mitoma, Francisco; Hamed, Kamal

The economic impact of blue-light filtering intraocular lenses on age-related macular degeneration associated with cataract surgery: a third-party payer's perspective
pp. 1311-1318(8)
Authors: Reddy, Prabashni; Gao, Xin; Barnes, Rod; Fairchild, Carol; Boci, Kreda; Waycaster, Curtis; Pashos, Chris

Physicians, patients, and public knowledge and perception regarding hypertension and stroke: a review of survey studies
pp. 1319-1330(12)
Authors: Volpe, Massimo; Dedhiya, Seema D.

A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients
pp. 1331-1341(11)
Authors: Boulenger, J.P.; Huusom, A.K.T.; Florea, I.; Bækdal, T.; Sarchiapone, M.

Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects
pp. 1343-1351(9)
Authors: Boyle, Julia; Eriksson, Malin; Stanley, Neil; Fujita, Tomoe; Kumagi, Yuji

Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies
pp. 1353-1367(15)
Authors: Smugar, Steven S.; Schnitzer, Thomas J.; Weaver, Arthur L.; Rubin, Bernard R.; Polis, Adam B.; Tershakovec, Andrew M.

Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L-thyroxine suppressive therapy
pp. 1369-1373(5)
Authors: Mazokopakis, Elias E.; Starakis, Ioannis K.; Papadomanolaki, Maria G.; Batistakis, Antony G.; Papadakis, John A.

Blood pressure reduction with olmesartan in mild-to-moderate essential hypertension: a planned interim analysis of an open label sub-study in German patients
pp. 1375-1380(6)
Authors: Böhm, Michael; Ewald, Silke; The Olmebest Study Authors,

The economic burden of gout on an employed population
pp. 1381-1389(9)
Authors: Brook, Richard A.; Kleinman, Nathan L.; Patel, Pankaj A.; Melkonian, Arthur K.; Brizee, Truman J.; Smeeding, James E.; Joseph-Ridge, Nancy

Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial
pp. 1391-1401(11)
Authors: Gana, Theophilus J.; Pascual, Maria Luz G.; Fleming, Rosa Rosanna B.; Schein, Jeff R.; Janagap, Carmela C.; Xiang, Jim; Vorsanger, Gary J.; The 023 Study Group,

Randomized, open-label comparison of epoetin alfa extended dosing (80 000 U Q2W) vs weekly dosing (40 000 U QW) in patients with chemotherapy-induced anemia
pp. 1403-1413(11)
Authors: Henry, David H.; Gordan, Lucio N.; Charu, Veena; Wilhelm, Francois E.; Williams, Denise; Xie, John; Woodman, Richard C.

Acarbose in addition to existing treatments in patients with type 2 diabetes: health economic analysis in a German setting
pp. 1415-1424(10)
Authors: Roze, Stéphane; Valentine, William J.; Evers, Thomas; Palmer, Andrew J.

Cost-effectiveness of alternative treatments for women with osteoporosis in Canada
pp. 1425-1436(12)
Authors: Goeree, Ron; Blackhouse, Gord; Adachi, Jonathan